Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Spironolactone does not increase the risk of breast cancer recurrence.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Finasteride use may increase the risk of male breast cancer.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

A rare ovarian tumor caused early puberty in a 3-year-old girl.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.